Department of Geriatrics, University Hospital Ghent, Ghent, Belgium.
Z Gerontol Geriatr. 2022 Mar;55(2):129-134. doi: 10.1007/s00391-022-02036-4. Epub 2022 Mar 4.
Coronavirus disease 2019 (COVID-19) has a high mortality, especially in the oldest old. Dying from COVID-19 is often characterized by symptoms such as breathlessness and agitation but data concerning medical treatment in the dying phase are limited.
This study describes the administration of oxygen, opioids and benzodiazepines in the last 24 h before death in patients 80 years or older dying from COVID-19 on acute hospital wards.
In this multi-centric retrospective study, patients, 80 years and older, admitted to the acute hospital in March and April 2020 were recruited from 10 acute Belgian hospitals. They all were diagnosed with COVID-19 and died on non-ICU wards with COVID-19. Administration of oxygen, opioids and benzodiazepines in the last 24 h before death was registered.
Eighty-five percent of patients received oxygen, half of them even by means of a mask providing at least 10l oxygen per minute. The majority (84.3%) of patients were treated with opioids (morphine). Mean dosage of SC morphine equivalent was 31.3 mg/24 h (range 2-120 mg; SD 21.6 mg). More than half of patients (52.8%) received benzodiazepines, mostly midazolam. Mean dosage of midazolam was 20.4 mg/24 h (range 1-100 mg; SD 15.4 mg). Dosages of morphine and midazolam did not differ depending on frailty or comorbidities. Older COVID-19 patients dying with respiratory failure had higher midazolam dosage (p 0.002) but not morphine dosage (p 0.11).
A high proportion of patients 80 years and older and dying with COVID-19 in the hospital, were treated with oxygen, opioids and benzodiazepines in the last 24 h before death. With this descriptive study, we hope to contribute to the discussion and further research on the optimization of symptom control in an older population dying from/with COVID-19.
2019 年冠状病毒病(COVID-19)死亡率较高,尤其是在最年长的人群中。死于 COVID-19 的人通常表现出呼吸困难和烦躁等症状,但有关临终阶段治疗的数据有限。
本研究描述了在 2020 年 3 月至 4 月期间,10 家比利时急性医院的 80 岁及以上因 COVID-19 住院的患者在死亡前 24 小时内接受的氧气、阿片类药物和苯二氮䓬类药物的治疗情况。
在这项多中心回顾性研究中,招募了来自 10 家急性比利时医院的 80 岁及以上因 COVID-19 急性住院并在非 ICU 病房死亡的患者。他们均被诊断为 COVID-19,并且在 COVID-19 病房死亡。记录了在死亡前 24 小时内接受的氧气、阿片类药物和苯二氮䓬类药物的使用情况。
85%的患者接受了氧气治疗,其中一半患者甚至通过提供至少 10L/分钟氧气的面罩进行氧疗。大多数(84.3%)患者接受了阿片类药物(吗啡)治疗。皮下注射吗啡等效剂量为 31.3mg/24h(范围 2-120mg;SD 21.6mg)。超过一半的患者(52.8%)接受了苯二氮䓬类药物治疗,主要是咪达唑仑。咪达唑仑的平均剂量为 20.4mg/24h(范围 1-100mg;SD 15.4mg)。吗啡和咪达唑仑的剂量与虚弱或合并症无关。因呼吸衰竭而死亡的老年 COVID-19 患者的咪达唑仑剂量较高(p0.002),但吗啡剂量无差异(p0.11)。
在因 COVID-19 住院并死亡的 80 岁及以上患者中,很大一部分患者在死亡前 24 小时内接受了氧气、阿片类药物和苯二氮䓬类药物的治疗。通过这项描述性研究,我们希望为讨论和进一步研究优化因 COVID-19 死亡或伴有 COVID-19 的老年人群的症状控制做出贡献。